Viewing Study NCT03020095


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-04-15 @ 5:05 PM
Study NCT ID: NCT03020095
Status: COMPLETED
Last Update Posted: 2020-10-22
First Post: 2017-01-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan
Sponsor: Ascletis Pharmaceuticals Co., Ltd.
Organization: